Colorectal cancer and hemoccult

Area of Science:

• Gastroenterology
• Oncology
• Medical Diagnostics

Background:

• Colorectal neoplasia presents a significant public health challenge.
• Early detection of colorectal neoplasia through screening is crucial for improving patient outcomes.
• The Hemoccult slide test is a widely used method for fecal occult blood testing.

Purpose of the Study:

• To evaluate the efficacy of the Hemoccult slide test as a screening tool for colorectal neoplasia.
• To compare the diagnostic yield of single-stool versus multiple-stool Hemoccult testing.

Main Methods:

• A single-stool Hemoccult test was performed on 300 unprepared patients.
• A three-stool Hemoccult test kit was distributed to over 2,500 individuals, with 1,160 returned for analysis.
• Positive Hemoccult tests were followed up with further investigations.

Main Results:

• The single-stool Hemoccult test yielded no diagnoses of colorectal neoplasia among 300 patients.
• The three-stool Hemoccult test identified 68 positive cases out of 1,160 participants.
• Follow-up investigations revealed three cases of colon carcinoma and nine cases of benign polyps (>1 cm) among the 58 patients investigated.
• The cost-effectiveness of the three-stool Hemoccult test was estimated at $2.50 per patient.

Conclusions:

• The single-stool Hemoccult test is not a reliable screening method for colorectal neoplasia.
• The three-stool Hemoccult test demonstrates potential for detecting colorectal neoplasia, including significant polyps and carcinomas.
• Further research may be warranted to optimize Hemoccult testing protocols for colorectal cancer screening.